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Background. The renal chloride channel ClC-5, which is re-
sponsible for Dent’s disease, is coexpressed with the vacuolar
H+-ATPase in proximal tubules (PT) and a-type intercalated
cells (IC) of the mature kidney. Neonatal cases of Dent’s dis-
ease suggest that ClC-5 distribution must be acquired before
birth. However, the ontogeny of ClC-5, and its processing and
segmental distribution with respect to related proteins during
nephrogenesis remain unknown.
Methods. Immunoblotting, real-time polymerase chain re-
action (RT-PCR), immunostaining, and deglycosylation stud-
ies were used to investigate the expression, distribution, and
maturation of ClC-5 during mouse and human nephrogene-
sis, in comparison with H+-ATPase, type II carbonic anhydrase
(CAII), and aquaporin-1 (AQP1).
Results. An early induction (E13.5-E14.5) of ClC-5 was ob-
served in mouse kidney, with persistence at high levels through
late nephrogenesis. This pattern contrasted with the progressive
expression of H+-ATPase and AQP1, and the postnatal upreg-
ulation of CAII. Immunostaining showed expression of ClC-5
in ureteric buds and, from E14.5, its location in developing PT.
From E15.5, ClC-5 codistributed with H+-ATPase in PT cells
and a-type IC. In the human kidney, ClC-5 was detected from
12 gestation weeks; its distribution was similar to that observed
in mouse, except for a later detection in IC. Although mouse
and human ClC-5 proteins are glycosylated, biochemical differ-
ences between fetal and adult proteins were observed in both
species.
Conclusion. The segmental expression of ClC-5 and H+-
ATPase is essentially achieved during early nephrogenesis, in
parallel with the onset of glomerular filtration. These data give
insight into PT and IC maturation, and explain early phenotypic
variants of Dent’s disease.
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ClC-5 is an integral plasma membrane protein that be-
longs to the CLC family of voltage-gated chloride chan-
nels [1]. ClC-5 is encoded by the CLCN5 gene, which is
located on Xp11.22 and is predominantly expressed in
the kidney [2]. Mutations in CLCN5 are associated with
Dent’s disease, an X-linked renal tubular disorder char-
acterized by low- molecular-weight proteinuria (LMWP)
and renal Fanconi syndrome, associated with hypercalci-
uria, nephrocalcinosis, and nephrolithiasis [3, 4]. Studies
in heterologous expression systems have shown that these
mutations abolish or markedly reduce the outwardly
rectifying chloride currents generated by ClC-5 [3].
The segmental expression of ClC-5 in the mature hu-
man and rat kidney includes the proximal tubule (PT),
the thick ascending limb (TAL) of Henle’s loop, and
the a-type intercalated cells (IC) of the collecting duct
(CD) [5–7]. The codistribution of ClC-5 with the vac-
uolar H+-ATPase in endosomes suggests that both pro-
teins could interact to regulate endosomal acidification
[5, 7] and apical targeting [8] in PT cells. The interaction
between ClC-5 and H+-ATPase may also be important
for the urinary acidification mediated by a-type IC [5–7].
These hypotheses are supported by the major defect in
receptor-mediated endocytosis associated with PT dys-
function reported in ClC-5–deficient mice [9, 10], as well
as by the alterations in polarity and expression of H+-
ATPase observed in PT cells and IC from patients with
Dent’s disease [8].
The clinical manifestations of Dent’s disease, including
hematuria, proteinuria, mild polyuria, and nephrolithia-
sis may often occur during childhood, and LMWP is a
consistent feature of the disease [4]. In particular, the
early onset of some cases [11, 12], in which tubular pro-
teinuria was discovered in the first month of life, suggests
that segmental expression of ClC-5 in PT must be ac-
quired before birth. Developmental studies in rats have
shown that assembly of brush border components coin-
cides with the onset of glomerular filtration [13], but the
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status of other components of the endocytic pathway in
PT cells, such as ClC-5 and H+-ATPase, is not known.
Similarly, studies in rat kidney have shown that IC ap-
pear during late nephrogenesis and undergo postnatal
maturation [14]. However, unlike rats, nephrogenesis in
mouse and humans is essentially achieved at birth, and
the pattern of appearance and differentiation of IC in
these two species remains unclear.
In this study, we have investigated the renal ontogeny,
processing, and distribution of ClC-5 during mouse and
human nephrogenesis, in parallel with that of the vacuolar
H+-ATPase, which provides the driving force for endo-
somal acidification in PT cells [15], type II carbonic an-
hydrase (CAII), which is essential for Na+ reabsorption
and urinary acidification in PT cells [16], and the water
channel aquaporin-1 (AQP1) as an ontogeny marker for
PT cells [17]. These studies provide new insights into the
maturation of PT and IC during nephrogenesis and help
to understand the role of ClC-5 and the early phenotypic
variants of Dent’s disease.
METHODS
Human and mouse kidney samples
Human fetal kidneys from therapeutic abortion were
procured by the International Institute for Advancement
of Medicine (Philadelphia, PA, USA), the Anatomic Gift
Foundation (Woodbine, GA,USA), and the Necker Hos-
pital (Paris, France). Eighteen human fetal kidneys, rang-
ing from 12 to 25 weeks of gestation (GW), were used for
immunoblotting and immunostaining studies. For com-
parison and additional studies, we also used 3 newborn
or infant human kidneys ranging in age from 4 months to
2 years. These normal kidneys were obtained directly at
surgery and perfused with ice-cold neutral buffered salt
solutions before processing for fixation and/or protein
extraction [7, 17]. The use of these samples conformed
to local ethical guidelines and were approved by the
University of Louvain Ethical Review Board.
Mouse kidney samples were obtained from CD-1 mice
(Iffa Credo, Brussels, Belgium). Pregnant mice were sac-
rified by cervical dislocation, and embryos were dissected
under a binocular to isolate kidneys. An average of 12
embryos from 4 different litters were collected every day
from embryonic day 13.5 (E13.5) until day 5 after birth
(newborn). Comparative studies were performed with 4
adult male kidneys. Kidney samples from wild-type ver-
sus ClC-5 knockout (KO) mice [10] and adult male Wistar
rats were also used.
Antibodies
Affinity-purified polyclonal antibodies (SB499) di-
rected against the N-terminus of human ClC-5 have
been characterized previously [10]. Other antibodies in-
cluded a monoclonal antibody against the 31 kD E sub-
unit (V1 domain) of the vacuolar H+-ATPase (a gift
of Dr. S. Gluck, Washington University, St. Louis, MO,
USA), a rabbit polyclonal antibody against the 116 kD
a4 subunit (V0 domain) of the vacuolar H+-ATPase
[18], a monoclonal antibody against b-actin (Sigma, St.
Louis, MO, USA), a rabbit polyclonal antibody against
AQP1 (Chemicon, Temecula, CA, USA), and sheep poly-
clonal antibodies against CAII (Serotec, Oxford, UK)
and Tamm-Horsfall protein (Biodesign International,
Kennebunk, ME, USA).
Immunoblot analyses and deglycosylation studies
Membrane extracts were prepared as previously de-
scribed [7, 10]. Briefly, kidney samples were homogenized
in ice-cold buffer (300 mmol/L sucrose and 25 mmol/L
N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid
made to pH 7.0 with 1 mol/L tris (hydroxymethyl)amino-
methane [Tris]) containing CompleteTM protease in-
hibitors (Roche, Vilvoorde, Belgium). The homogenate
was centrifuged at 1000g for 15 minutes at 4◦C, and the
resulting supernatant was centrifuged at 100,000g for
120 minutes at 4◦C. The pellet (“membrane” fraction)
was suspended in ice-cold homogenization buffer before
determination of protein concentration and storage
at –80◦C.
Deglycosylation studies were performed on human
and mouse kidney extracts and control glycoproteins
(Roche). The samples (15 lg total protein) were incu-
bated for 60 to 90 minutes at 37◦C with 12 units of N-
glycosidase F, as recommended by the manufacturer.
Immunoblotting was performed as previously de-
scribed [7, 10]. After blocking, membranes were incu-
bated overnight at 4◦C with primary antibodies, washed,
incubated for 1 hour at room temperature with appro-
priate peroxidase-labeled antibodies (Dako, Glostrup,
Denmark), washed again, and visualized with enhanced
chemiluminescence. Normalization for b-actin was ob-
tained after stripping the blots and reprobing with the
anti-b-actin antibody. Specificity of the immunoblot was
determined by incubation with: (1) preimmune rabbit
serum; (2) nonimmune rabbit or mouse immunoglobulin
(Ig)G (Vector Laboratories, Burlingame, CA, USA) or
control ascites fluid (Sigma); and (3) anti-ClC5 antibody
preadsorbed with a 5-fold (w/w) excess of immunogenic
peptide. Determination of the molecular mass was ob-
tained by comparison with different precision standards
(MBI Fermentas, Vilnius, Lithuana; Bio-Rad, Hercules,
CA, USA). Densitometry analysis of the specific bands
was performed with a Hewlett Packard Scanjet model
IVC using the National Institutes of Health (NIH) Im-
age V1.60 software, and optical densities normalized to
b−actin density in the corresponding sample. All im-
munoblots were at least performed in duplicate.
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RT-PCR and semiquantitative RT-PCR
Mouse kidney samples were homogenized in Trizol (In-
vitrogen, Merelbeke, Belgium) in order to extract total
RNA. Total RNA samples (2.7 lg) were treated with
DNase I (Invitrogen) and reverse-transcribed into cDNA
using SuperScript II Rnase H Reverse Transcriptase (In-
vitrogen). The following primers were designed using
Beacon Designer 2.0 (Premier Biosoft International, Palo
Alto, CA, USA): ClC-5 (exon 6) sense 5′AAGTGG
ACCCTTGTCATCAA 3′ and antisense 5′ACAAG
ATGTTCCCACAGCAG 3′, AQP1 (exons 1–2) sense 5′
GCTGTCATGTATATCATCGCCCAG 3′ and antisense
5′ AGGTCATTTCGGCCAAGTGAGT 3′, GAPDH
(exon 1) sense 5′ TGCACCACCAACTGCTTAGC 3′
and antisense 5′ GGATGCAGGGATGATGTTCT 3′.
The predicted lengths of the resulting PCR fragments
were 115 bp (ClC-5), 107 bp (AQP1), and 176 bp
(GAPDH). RT-PCR reactions were performed with 200
nmol/L of both sense and antisense primers in a final
volume of 25 lL using 1 unit of Platinum Taq DNA poly-
merase, 2 mmol/L MgCl2, 400 lmol/L dNTP. PCR con-
ditions were 94◦C for 5 minutes followed by 35 (ClC-5),
36 (AQP1), and 30 (GAPDH) cycles of 30 seconds at
95◦C, 30 seconds at 61◦C, and 1 minute at 72◦C. The
PCR products were size-fractionated on 1.5% agarose
gel and then stained with ethidium bromide. Negative
controls confirmed that the samples were not cross-
contaminated (sterile water instead of RNA) or pol-
luted by genomic DNA (not reverse-transcribed RNA
samples). The expression of ClC-5 was also verified us-
ing another set of primers (exons 8–9), sense 5′ TCC
GCACAAACATTGCCTG 3′ and antisense 5′ AGGC
AGCAGCCCCAACCAT 3′ (predicted length of the
fragment: 519 bp).
Real-time PCR analyses were performed in duplicate
with 200 nmol/L of both sense and anti-sense primers in
a final volume of 25 lL using 1 U of Platinum Taq DNA
Polymerase, 2 mmol/L MgSO4, 400 lmol/L dNTP, and
SYBR Green I (Molecular Probe, Leiden, The Nether-
lands) diluted to 1/105. PCR mixture contained 10 nmol/L
fluorescein for initial well to well fluorescence normal-
ization. PCR conditions were settled as incubation at
94◦C for 3 minutes followed by 40 cycles of 30 seconds
at 95◦C, 30 seconds at 61◦C, and 1 minute at 72◦C. The
melting temperature of PCR product was checked at the
end of each PCR by recording SYBR green fluorescence
increase upon slowly renaturating DNA. For each as-
say, standard curves were prepared by serial 4-fold di-
lutions of mouse adult kidney cDNA. The mRNA levels
of ClC-5 and AQP1 were adjusted to GAPDH mRNA
level at each stage, and relative changes in mRNA levels
during ontogeny were determined by comparison to the
adult mRNA level using the following formula: Ratio =
(Etarget)Ct(Adult-Sample)/(EGAPDH)Ct(Adult-Sample) [19].
Immunostaining
Kidney samples were fixed in 4% paraformalde-
hyde (Boehringer Ingelheim, Heidelberg, Germany) in
0.1 mol/L phosphate buffer, pH 7.4, prior to embed-
ding in paraffin as described [7, 10, 17]. Six lm sections
were incubated for 30 minutes with 0.3% hydrogen per-
oxide to block endogenous peroxidase. For ClC-5 and
H+-ATPase immunostaining, antigen retrieval was per-
formed by incubating sections in 0.01 mol/L citrate buffer,
pH 5.8, for 75 minutes, in a water bath heated at 97◦C,
before cooling down and rinsing. Following incubation
with 10% normal serum for 20 minutes, sections were
incubated for 45 minutes with the primary antibodies di-
luted in phosphate-buffered saline (PBS) containing 2%
bovine serum albumin (BSA). After washing, sections
were successively incubated with biotinylated secondary
anti-immunoglobulin (Ig)G antibodies, avidin-biotin per-
oxidase, and aminoethylcarbazole (Vectastain Elite, Vec-
tor Laboratories). Sections were viewed under a Leica
DMR coupled to a Leica DC300 digital camera (Leica,
Heerbrugg, Switzerland). The specificity of immunostain-
ing was tested by incubation: (1) in absence of primary
antiserum; (2) with preimmune rabbit serum; (3) with
non-immune rabbit serum or control rabbit or mouse
IgG (Vector Laboratories); and (4) with the anti-ClC-
5 antibody preadsorbed with the immunogenic peptide.
The intensity of immunostaining was graded by an obser-
vator unaware of the embryonic stage and the antibody
used, in comparison with the intensity observed in adult
samples.
RESULTS
Comparative ontogeny of ClC-5 in the mouse kidney
ClC-5 was detected as a broad band at ∼80 kD in the
adult mouse kidney (Fig. 1A). The band was not detected
in kidney extracts from Clcn5 KO mouse (left panel), or
when the blot was incubated with anti-ClC-5 antibodies
preadsorbed with the immunogenic peptide (right panel).
The signal for ClC-5 observed in embryonic samples was
different from the adult (right panel); it included two
bands at ∼90 kD and ∼75 kD, respectively, separated by a
smear of diffuse immunoreactive bands. With the excep-
tion of the upper band at ∼90 kD, all the immunoreactive
bands were abolished when using preadsorbed antibodies
(right panel).
The expression of ClC-5 in the developing kidney was
already detected at E13.5 (Fig. 1B). At this early stage, the
immunoreactive pattern was characterized by the non-
specific upper band at ∼90 kD, and the diffuse specific
bands including the ∼75 kD band. The signal intensity for
ClC-5 peaked early (E14.5), and remained quite stable to
E16.5. From E16.5 to the newborn stage, the immunore-
activity pattern for ClC-5 showed a progressive decrease
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Fig. 1. Comparative ontogeny of ClC-5 in mouse kidney. (A) Char-
acterization of the SB499 anti-ClC-5 antibodies. Left: Kidney extracts
(30 lg/lane) from wild-type (WT) and knockout (KO) ClCn5 mice were
run on 7.5% PAGE and transferred to nitrocellulose. The blot was
probed with SB499 anti-ClC-5 antibodies (1:1000). The diffuse band
corresponding to ClC-5 at ∼80 kD is absent in KO mice. The membranes
in the higher molecular mass isoforms and apparition of
a more focused signal around 75 to 80 kD. Adult sam-
ples were characterized by concentrated immunoreactive
bands around 80 kD, as described above.
The expression of AQP1 in the kidney is character-
ized by two isoforms—the core AQP1 (28 kD) and the
glycosylated AQP1 (GlyAQP1, 35 to 50 kD). The core
AQP1 was detected at E15.5 and it gradually increased
during late ontogeny. The GlyAQP1 was detected only
at E18.5 and in the newborn kidney, probably reflecting
the increased amount of AQP1 [17]. The 31 kD band
corresponding to the E1 subunit of the H+-ATPase was
detected at low level from E13.5 and showed a gradual
increase from E16.5 to birth. A progressive induction of
the 116 kD a4 subunit of the H+-ATPase from E16.5,
in parallel with the E subunit, was observed in devel-
oping mouse kidney (data not shown). The CAII band
at 30 kD was detected at E14.5, remained stable during
all ontogeny, and showed a dramatic increase postnatally
(Fig. 1B). Densitometry analysis (Fig. 1C) confirmed the
different expression patterns of ClC-5, which peaked at
E14.5 (170% of adult level), remained high (140% to
150% of adult level) during ontogeny, and decreased af-
ter birth, AQP1 and H+-ATPase, which showed a gradual
increase from E16.5, and CAII, with low expression lev-
els (15% - 30% of adult level) during all ontogeny and a
significant postnatal increase.
Quantification of ClC-5 mRNA expression in
the developing mouse kidney
Semiquantitative (Fig. 2A) and real-time PCR analy-
ses (Fig. 2B) confirmed the early induction of ClC-5 at
were stripped and reincubated with a monoclonal antibody
against b-actin (1:10,000). Right: Adult and fetal (E18.5) mouse
kidney extracts (20 lg/lane) were run on 7.5% PAGE and transferred
to nitrocellulose. Identical strips were probed with control (SB499;
1:1000) or preadsorbed (PreAd; 1:1000) SB499 anti-ClC-5 antibodies.
With the exception of the nonspecific upper band at ∼90 kD detected
in fetal samples, the distinct signal corresponding to ClC-5 in mature
and developing kidney is abolished when incubation is performed
with preadsorbed antibodies. Reprobing for b-actin was performed
as above. (B) Representative immunoblots for ClC-5 in extracts from
adult rat (positive control, C) and mouse at different stages—from
E13.5 to E18.5, neonates (NB) and adults. Twenty lg of protein
were loaded in each lane, and blots were probed with antibodies
against ClC-5 (1:1000), AQP1 (1:20,000), H+-ATPase (1:100), CAII
(1:1000), and after stripping, b-actin (1:10,000). ClC-5 is detected at
E13.5, upregulated at E14.5, and then sustained during ontogeny. The
immunoreactive pattern is also clearly different in the early (higher
molecular mass bands) and late stages (focused immunoreactive
bands around 75–80 kD) of maturation. The expression of AQP1 and
H+-ATPase gradually increases from E16.5 and during late ontogeny,
whereas CAII expression is characterized by post-natal upregulation.
(C) Expression of ClC-5, AQP1, H+-ATPase, and CAII during mouse
nephrogenesis: densitometry analyses of immunoblots. Values were
obtained from duplicate blots and, after normalization over b-actin in
each lane, compared with the adult kidney taken as the 100% reference.
The early induction of ClC-5 contrasts with the progressive increase in
AQP1 and H+-ATPase, and with the postnatal upregulation of CAII.
The densitometry analyses of ClC-5 included all bands detected below
the upper, nonspecific band at ∼90 kD (see A).
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Fig. 2. Differential expression of ClC-5 and AQP1 in the developing
mouse kidney: semi-quantitative and real-time PCR analysis. (A) Rep-
resentative semiquantitative RT-PCR analysis of the expression of ClC-
5, AQP1, and GAPDH during embryogenesis (E13.5, E15.5, E17.5) and
in newborn (NB) and adult (A) mouse kidneys. Negative controls with
water (W) and in absence of RT product (N) are shown. (B) Quanti-
tative RT-PCR of ClC-5 and AQP1 mRNA expression during mouse
nephrogenesis. The primers for ClC-5, AQP1, and GAPDH were sim-
ilar to those used above. The ClC-5 and AQP1 mRNA levels were
adjusted to GAPDH for each stage. The relative changes in expression
during ontogeny were determined by comparison to the adult mRNA
level taken as 100%. ClC-5 mRNA is significantly expressed at E13.5
(70% of the adult value), with a subsequent decrease until E17.5 (30%)
and a major 2-fold upregulation at birth. This expression pattern con-
trasts with the low level of AQP1 at E13.5 (4% of the adult value) and
its gradual increase from E15.5 (6%) to nearly reach the adult level at
birth (73%).
E13.5, with a slight decrease of expression during late
ontogeny, and a dramatic 2-fold increase in newborns.
This expression pattern contrasted with that of the water
channel AQP1, which showed a later induction at the end
of nephrogenesis to nearly reach the adult level at birth.
Processing of ClC-5 during mouse nephrogenesis:
Deglycosylation studies
Sequence analysis predicted that ClC-5 is a glycopro-
tein with N-glycans linked to Asn at position 408 [3].
Deglycosylation studies with N-glycosidase F were per-
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Fig. 3. Processing and glycosylation of ClC-5 in mouse kidney. The
samples [(A) E15.5; (B) adult] were incubated with the reaction buffer
containing (+) or not (−) N-glycosidase F, separated (7.5 lg pro-
tein/lane) on 7.5% PAGE and probed with anti-ClC5 antibodies alone
(SB499) or preadsorbed (PreAd) (both diluted 1:1000). Untreated em-
bryonic samples (A) are characterized by diffuse immunoreactive ClC-5
bands (asterisk), located below the nonspecific 90 kD band, and by a
75 kD band (arrow). Incubation in the reaction buffer yielded a non-
specific immunoreactive band at 60 kD (arrowhead) in all samples. Un-
treated adult samples (B) do not show the 75 kD band (arrow), but are
characterized by a focused band at ∼80 kD (asterisk), in addition to
the nonspecific band at 60 kD (arrowhead). The shift of ClC-5-positive
bands to a lower molecular weight after N-glycosidase F treatment in-
dicates the existence of Asn-linked glycan chains in both embryonic
and adult samples. It must be noted that embryonic samples differ from
adult by the existence of a 75 kD, PGNase F-insensitive band, as well
as by the higher molecular mass of the PGNase F-sensitive proteins in
control and treated conditions.
formed in control glycoproteins and developing and adult
mouse kidney samples (Fig. 3). Digestion of transferrin
(65 to 60 kD), a1-acid glycoprotein (45 to 22 kD), and ri-
bonuclease B (17 to 15 kD) demonstrated the efficiency
of deglycosylation (data not shown). Immunoblot analy-
sis showed that untreated embryonic samples (Fig. 3A)
are characterized by diffuse immunoreactive ClC-5 bands
(asterisk) located below the nonspecific 90 kD band
and a specific, core band at ∼75 kD (arrow). The lat-
ter is above a nonspecific immunoreactive band at 60 kD
(arrowhead), which results from incubation in reaction
buffer. Untreated adult samples (Fig. 3B) showed the
mature ClC-5 band at ∼80 kD (asterisk) in addition to
the nonspecific band at 60 kD (arrowhead), but not the
75 kD core band (arrow). Treatment with N-glycosidase
F yielded a shift of the specific ClC-5–positive bands to
a lower apparent molecular weight, indicating the exis-
tence of Asn-linked glycan chains in both embryonic and
adult samples. To note, the molecular weight of the degly-
cosylated form of ClC-5 was slightly higher in developing
than in mature kidney samples.
Ontogeny and glycosylation of ClC-5 in the
human kidney
The broad immunoreactive band corresponding to
ClC-5 was detected by immunoblotting in the develop-
ing human kidney at 12GW (Fig. 4A). The intensity of
ClC-5 expression was sustained during all nephrogene-
sis, similar to that observed in the infant kidney. Treat-
ment with N-glycosidase F induced a significant shift of
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Fig. 4. Ontogeny and glycosylation of ClC-5 in the human kidney. (A)
Representative immunoblot for ClC-5 in membrane extracts from rat
kidney (positive control, RKC), human fetal kidney (HFK) at 12, 13, 18,
and 25 GW, newborn (HNK) and infant (HIK) human kidney. Thirty
lg of protein were loaded in each lane, and the blot was probed with
the anti-ClC-5 antibodies alone (SB499) or preadsorbed (PreAd) (both
diluted 1:1000). The broad band corresponding to ClC-5 is detected at
12 GW, and its expression is sustained during nephrogenesis. The ClC-
5 signal is abolished when incubation is performed with preadsorbed
antibodies. Discrete bands below 60 kD are also detected with nonim-
mune IgG. (B) Deglycosylation with N-glycosidase F in human kidney
samples (25 GW, HFK25; infant, HIK). The samples were incubated
with the reaction buffer containing (+) or not (−) N-glycosidase F, sep-
arated (7.5 lg protein/lane) on 7.5% PAGE and probed with anti-ClC-5
antibodies (SB 499 lanes). The shift of ClC-5 bands to a lower molec-
ular weight confirms the existence of Asn-linked glycan chains. As in
mouse, the molecular mass of the PGNase F-sensitive ClC-5 proteins is
higher in fetal than in postnatal samples. The pattern observed in HIK
samples (more diffuse immunoreactive bands including lower mass iso-
forms) suggests that they may include residual embryonic isoforms. The
signal is abolished when a similar blot is incubated with preadsorbed
anti-ClC-5 antibodies (PreAd).
ClC-5–positive bands to a lower molecular weight
(Fig. 4B), indicating the existence of Asn-linked glycan
chains in developing and mature human kidney samples.
As described in mouse, the molecular weight of the deg-
lycosylated form of ClC-5 was higher in fetal than in post-
natal samples.
Segmental distribution of ClC-5 during
mouse nephrogenesis
ClC-5 was detected in the developing mouse kidney
at E13.5 (Fig. 5A). The signal was located in branching
Fig. 5. Immunodetection of ClC-5 in the developing mouse kidney.
(A) The staining for ClC-5 is first detected in the ureteric buds (arrow-
heads) located in the inner part of the primitive cortex at E13.5. (B)
The staining intensity markedly increases at E14.5, with ClC-5 being
located primarily in the ureteric buds (arrowheads) and developing PT
(p). (C) ClC-5 staining at E15.5 and (D) E18.5 is observed in ureteric
buds (arrowheads), and its intensity increases in developing PT (p); IC
are detected from E15.5 (asterisks). Glomeruli, condensates, comma-
and S-shaped bodies are negative (Original magnification A-D, × 150).
ureteric buds within the inner part of the primitive cor-
tex, whereas the undifferentiated metanephric cap tissue,
the condensates, and the inner mesenchyme, were nega-
tive. Staining intensity for ClC-5 markedly increased at
E14.5, by which dispersed primitive glomeruli were iden-
tified (Fig. 5B). The staining was stronger in the ureteric
buds and also appeared in developing PT. Glomeruli, as
well as comma- and S-shaped bodies, were all negative.
From E15.5 (Fig. 5C) to E18.5 (Fig. 5D), ClC-5 stain-
ing persisted in ureteric buds, became more apparent in
developing PT, and gradually appeared in the IC.
At higher magnification (Fig. 6), staining for ClC-5
within the primitive cortex of E14.5 kidneys was identi-
fied in the apical area of the tips of ureteric buds (Fig. 6A).
A similar staining was observed within branching ureteric
buds in the outer part of the primitive medulla (Fig. 6B),
whereas an apical staining restricted to a subpopulation
of ureteric buds cells was observed in the inner medulla
(Fig. 6C). At E15.5, ClC-5 was identified in PT originat-
ing from recently formed glomeruli, and scattered CD
cells (Fig. 6D and inset). The latter were also stained for
apical H+-ATPase, indicating that they correspond to a-
type IC (see below). At E16.5, ClC-5 showed an homo-
geneous, subapical staining in cells lining developing PT,
and a strong apical staining in IC (Fig. 6E). To note, codis-
tribution of ClC-5 (Fig. 6F) and Tamm-Horsfall protein
(Fig. 6G) was observed in some juxtaglomerular tubules
at E16.5 and later. Distribution of ClC-5 in E18.5 kidneys
included the apical area of PT cells and IC of the cortical
CD (Fig. 6H), exactly like in newborn mouse (Fig. 6I).
Codistribution of ClC-5 (Fig. 6J) and CAII (Fig. 6K)
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Fig. 6. Segmental distribution of ClC-5 during mouse nephrogenesis.
(A, B, C, D, E, F, H, I, J) Immunostaining for ClC-5, (G) Tamm-Horsfall
protein, and (K) CAII in the developing mouse kidney at (A–C) E14.5,
(D) E15.5, (E–G) E16.5, (H) E18.5 (H), (I–K) and newborn kidney.
At E14.5, staining for ClC-5 is restricted to the apical area of the (A,
B) ureteric buds, and in a subpopulation of ureteric buds cells in the
(C) inner medulla. At E15.5, ClC-5 is located in developing PT and
scattered cells within developing CD in the (D) outer cortex. At (E)
E16.5, linear apical ClC-5 staining is detected in PT cells, paralleled
by a strong apical staining in IC within CD. Staining on serial sections
from E16.5 kidneys shows codistribution of (F) ClC-5 and (G) Tamm-
Horsfall protein in juxtaglomerular tubules. The distribution of ClC-5
in PT and IC is exactly similar in (H) E18.5 and (I) newborn kidneys.
Staining on serial sections shows the codistribution of (J) ClC-5 and (K)
CAII in postnatal IC. (Original magnification: A–C, E, H, I, × 310; D,
F, G, J, K, ×410).
was observed in postnatal IC. The specificity of ClC-5
staining was demonstrated with preadsorbed SB499 an-
tibodies (data not shown). In comparison with ClC-5,
CAII was first identified in IC at E15.5 and PT cells at
E16.5, whereas AQP1 was detected in PT cells from E16.5
(data not shown). The distribution of ClC-5 and tubular
markers during mouse nephrogenesis is summarized in
Table 1.
Segmental distribution of H+-ATPase during
mouse nephrogenesis
Staining for H+-ATPase was detected in the develop-
ing mouse kidney at E15.5 (Fig. 7A). The signal was lo-
cated in the subapical area of developing PT in the inner
cortex (Fig. 7E), whereas ureteric buds, glomeruli and
undifferentiated structures were negative. Apical stain-
ing for H+-ATPase was also identified in scattered IC
Fig. 7. Segmental distribution of H+-ATPase in the developing mouse
kidney. (A–L) Immunostaining for H+-ATPase, and (K, M) ClC-5 in
the developing mouse kidney at (A, E, F) E15.5 (B, G, H) E16.5 (C,
J–M) E18.5, and (D, I) newborn kidney. (A) Staining for H+-ATPase
is detected in developing tubules in the inner cortex at E15.5. (B) A
progressive increase in staining is then observed at E16.5, (C) E18.5, and
further in the (D) newborn, with a distribution that includes developing
PT in the cortex and scattered IC within cortical and medullary CD. (E,
F) At E15.5, H+-ATPase is located in the subapical area of developing
(E) PT cells and scattered IC in (F) cortical CD. Numerous positive
IC are also detected in the (G) cortical and (H) inner-medullary CD
at E16.5. The H+-ATPase distribution during late ontogeny is similar
to that observed in the (I) newborn kidney, including linear, subapical
staining in PT cells and focal, apical staining in a-type IC. Staining on
serial sections confirmed the colocalization of (K, M) ClC-5 with (J, L)
H+-ATPase in (J, K) PT and (L, M) a-type IC. (Original magnification:
A–D, × 80; E, F, I–M: ×330; G, H, × 385).
(Fig. 7F). A significant increase in H+-ATPase expression
was detected at E16.5 (Fig. 7B), with staining of develop-
ing PT and IC in the cortex and inner medulla (Fig. 7G
and H). The IC in the medulla were characterized by
apical protrusion into the lumen (Fig. 7H), unlike those
observed in the cortex (Fig. 7G). The distribution of H+-
ATPase at E18.5 (Fig. 7C) was similar to that observed in
the newborn mouse kidney (Fig. 7D and I) and included
PT cells (linear, subapical staining) and IC (punctuated,
apical staining). H+-ATPase (Fig. 7J and L) and ClC-5
(Fig. K and M) colocalized in the developing PT and IC
as early as E15.5 (see Table 1 for summary).
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Table 1. Distribution of ClC-5, H+-ATPase, AQP1, and CAII in the developing mouse kidney: Summary
E13.5 E14.5 E15.5 E16.5 E17.5 E18.5 Newborn
PT ClC-5 (–) (+) (++) (+++) (+++) (+++) (+++)
H+-ATPase (–) (–) (+) (++) ND (+++) (+++)
AQP1 (–) (–) (–) (+) (++) (+++) (+++)
CA II (–) (–) (–) (+) ND (++) (+++)
CCD ClC-5 (+)UB tips (++) UB tips (++)UB tips (++) UB tips (++) UB tips Rare (++) UB tips Rare (+) UB tips
Rare IC Numerous IC Numerous IC Numerous IC Numerous IC
H+-ATPase (–) (–) Rare IC Numerous IC ND Numerous IC Numerous IC
AQP1 (–) (–) (–) (–) (–) (–) (–)
CA II (–) (–) Rare IC Rare IC ND Numerous IC Numerous IC
MCD ClC-5 (–) Rare UB cells Rare IC Numerous IC Numerous IC Numerous IC Numerous IC
H+-ATPase (–) (–) Rare IC Numerous IC ND Numerous IC Numerous IC
AQP1 (–) (–) (–) (–) (–) (–) (–)
CA II (–) (–) (–) Rare IC ND Numerous IC Numerous IC
Abbreviations are: PT, proximal tubule; CCD, cortical collecting duct; MCD, medullary collecting duct; UB, ureteric bud; IC, intercalated cells; ND, not done.
Intensity of staining was graded as (–), absent; (+), weak; (++), moderate; (+++), strong.
Segmental distribution of ClC-5 and H+-ATPase in
the developing human kidney
Diffuse staining for ClC-5 was identified in 13GW
kidneys, located in developing PT from juxtamedullary
nephrons (Fig. 8A and C). No specific staining was de-
tected in condensates, comma and S-shaped bodies, and
glomeruli. At 19 GW, a slightly more intense staining
for ClC-5 was detected in maturing PT (Fig. 8B and D),
whereas no specific staining was detected with pread-
sorbed SB499 antibodies (Fig. 8E). The distribution of
ClC-5 in developing PT was confirmed in serial sections
stained for AQP1; to note, the staining for AQP1 was
more polarized than ClC-5 at that stage (Fig. 8F and
G). In juxtamedullary nephrons, ClC-5 was also located
in juxtaglomerular tubule profiles that were positive for
Tamm-Horsfall protein (Fig. 8H and I). In contrast with
CAII (15GW) and H+-ATPase (19GW), ClC-5 could not
be clearly identified in IC until the 24 GW (data not
shown). Identification of ClC-5 staining in IC was ascer-
tained postnatally by colocalization with CAII (Fig. 8J
and K).
A faint signal for H+-ATPase (Fig. 9) was detected at
13 GW in the apical area of developing PT in the outer
cortex, whereas glomeruli and ureteric buds were nega-
tive (Fig. 9A). From 15 GW to 24 GW (Fig. 9B), a pro-
gressive increase in H+-ATPase expression was detected
in the subapical area of PT cells. Isolated cells positive for
H+-ATPase (Fig. 9B) were also identified in the CD as
early as 19 GW (inset of Fig. 9B). The reactivity for H+-
ATPase after birth included a strong signal in the apical
area of PT cells and IC of the CD (Fig. 9C).
DISCUSSION
Our studies show that ClC-5 undergoes a rapid induc-
tion at an early stage of mouse nephrogenesis, followed by
a progressive maturation during late nephrogenesis. This
ontogeny pattern is distinct from the progressive increase
of H+-ATPase and AQP1 expression, and the postnatal
induction of CAII. Studies with PGNase F confirm the
early N-linked glycosylation of ClC-5, and the progres-
sive maturation of the core protein during nephrogene-
sis. The distribution of ClC-5 in PT and a-type IC, and
its colocalization with H+-ATPase in these locations, are
already achieved at E15.5 (see Table 1 for summary). In
human nephrogenesis, ClC-5 is detected early during the
second trimester, with a distribution that includes devel-
oping PT cells and later, IC.
Nephrogenesis in mouse and humans is characterized
by a repetitive and reciprocal induction between the
ureteric bud and the metanephric mesenchyme, resulting
in the formation of a mature kidney before birth. In other
species, such as rat or rabbit, nephrogenesis continues af-
ter birth ([20] for review). Glomerular filtration starts at
E14 in mouse [21], and between the 9th and 12th GW in
the human kidney [22]. The molecular events that take
place in renal tubular cells following the onset of glomeru-
lar filtration remain partially unknown. The reabsorption
of LMW proteins that are freely filtered is confined to
PT cells, which are characterized by an intense endocytic
activity followed by transport and degradation into the
acidic vacuolar-lysosomal system [23]. Indirect evidence
in rats [24] and humans [25] suggests that the PT endo-
cytic activity is effective during nephrogenesis or immedi-
ately after birth. Furthermore, an increase of transporting
membrane area and CA activity, as well as the upregu-
lation of AQP1, has been documented in PT cells dur-
ing nephrogenesis [17, 22, 26]. In contrast, the ontogeny
and distribution of intracellular transporters such as ClC-
5 and H+-ATPase during nephrogenesis have not been
characterized to date. The issue is particularly relevant
for PT maturation, since several lines of evidence suggest
that ClC-5 interacts with the vacuolar H+-ATPase [8] and
plays an essential role in the megalin receptor-mediated
endocytic pathway [5, 7, 9, 10].
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Fig. 8. Segmental distribution and co-localization of ClC-5 in the de-
veloping human kidney. Immunostaining for (A–F, H, J) ClC-5, (G)
AQP1, (I) Tamm-Horsfall protein, and (K) CAII in the developing hu-
man kidney at (A, C) 13 GW, (E) 17 GW, (B, D) 19 GW, (F–I) 24 GW,
and in a (J, K) 4-month infant kidney. Diffuse staining for ClC-5 is iden-
tified in developing PT (p) from juxtamedullary nephrons at 13GW,
whereas (A, C) glomeruli are negative. A similar pattern is observed at
19 GW, with a slightly more intense staining for ClC-5 in maturing (B,
D) PT. No specific staining is observed when using preadsorbed SB499
antibodies on similar sections (E). Staining on serial sections from 24
GW human kidneys demonstrated the colocalization of (F) ClC-5 and
(G) AQP1 in PT. ClC-5 is also located in juxtamedullary tubule profiles
(H, arrowheads) positive for (I) Tamm-Horsfall protein. Identification
of ClC-5 staining in IC (J, arrowhead) is confirmed by colocalization
with (K) CAII in serial sections from a 4-month-old kidney. (Original
magnification: A, B, × 150; C, J, K, × 300; D, E, H, I, ×320; F, G, × 280).
Immunoblotting and RT-PCR analyses show that ClC-
5 undergoes a rapid induction in the developing mouse
kidney, followed by progressive maturation during late
ontogeny and a marked induction just after birth (Figs. 1
and 2). Thus, the developmental pattern of ClC-5 expres-
sion in mouse clearly differs from that of another glyco-
protein such as AQP1, or the co-expressed H+-ATPase.
Studies with PGNase F not only confirmed the early
N-glycosylation of ClC-5 [30] but also demonstrated bio-
chemical differences between embryonic and adult ClC-5
proteins. These differences include the higher molecular
mass of the PGNase F-sensitive proteins in embryonic
versus adult samples, as well as the specific expression in
mouse embryonic samples of a ClC-5 isoform (∼75 kD)
that is resistant to PGNase F treatment and that may
correspond to the “core” ClC-5 protein (Fig. 3). By anal-
ogy with other members of the CLC family, the com-
plex maturation of ClC-5 may result from alternative
splicing [27, 28], post-translational modifications [29], or
covalent binding to proteins that are expressed during
Fig. 9. Segmental distribution of H+-ATPase during human nephro-
genesis. (A) At 13 GW, a faint signal for H+-ATPase is detected in the
apical region of the developing PT (p) in the outer cortex. Glomeruli
(g) and ureteric buds (u) are negative. (B) At 24 GW, H+-ATPase is
located in PT cells (p) and IC (arrowhead). To note, the latter are al-
ready positive for H+-ATPase at 19 GW (inset). (C) Typical staining
for H+-ATPase in a 2-year-old kidney includes PT cells and a-type IC
within CD. (Original magnification: A, × 225; B–D, × 425).
nephrogenesis [20]. It is tempting to hypothesize that
the transient expression of immature ClC-5 isoforms dur-
ing ontogeny may correspond to the signal observed in
ureteric buds, where there is no colocalization with H+-
ATPase, whereas a progressive increase in mature ClC-5
isoforms may actually parallel the induction of H+-
ATPase during late nephrogenesis. These results, and the
postnatal regulation of CAII (Fig. 1C), confirm recent
evidence showing that differentially regulated genes, in-
cluding transporters, ion-motive ATPases, and enzymes,
can be grouped in clusters that participate in different
steps of kidney organogenesis [31].
As summarized in Table 1, the segmental expression of
ClC-5 and H+-ATPase in PT cells is already detected at
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E15.5 in mouse (Figs. 5 to 7), and essentially achieved dur-
ing the second trimester of gestation in humans (Fig. 8).
These results complete early observations that the api-
cal expression of brush border components and the
distribution of megalin to the apical clathrin-coated mem-
brane domains and endosomes coincide with the onset of
glomerular filtration in rats [13, 32]. The coexpression
of ClC-5 and H+-ATPase in PT cells immediately after
initiation of glomerular filtration could thus indicate the
progressive maturation of renal tubular function and ex-
plain the decrease in the concentration of LMW proteins
in the amniotic fluid during gestation [25]. These data also
help to understand the pathophysiology of early pheno-
typic variants of Dent’s disease, in which LMWP has been
identified during the first weeks of life [11, 12].
In addition to PT cells, ClC-5 and H+-ATPase are code-
tected from E15.5 in the apical area of isolated cells within
the CD. The apical polarity of both markers allow to iden-
tify these cells as a-type IC, which, in the mature kidney,
are primarily involved in urinary acidification. Studies in
rat have shown that a-type IC simultaneously express
H+-ATPase and CAII at the end of the gestation, mature
and increase in number during the first weeks of life, and
are then partially removed from the CD [14, 33]. Our re-
sults provide additional informations on IC maturation in
mouse and human nephrogenesis. In mouse nephrogen-
esis, isolated cells of the medullary ureteric buds, positive
for ClC-5, are detected as early as E14.5. IC positive for
ClC-5, H+-ATPase, and CAII are observed in the corti-
cal CD at E15.5. In human nephrogenesis, isolated cells
positive for CAII are identified within ureteric buds and
medullary CD at 15 GW, and rare, isolated cells positive
for H+-ATPase are identified at 19 GW. In contrast, ClC-
5 could not be identifed in IC before 24 GW. The colo-
calization of ClC-5 with CAII and/or H+-ATPase in IC
was only observed postnatally, confirming data obtained
in mature kidney [5, 7]. These results suggest species dif-
ferences in the maturation of IC [14, 33] and support the
hypothesis that, in humans, the differentiation of IC oc-
curs later than that of the principal cells of the CD [17].
Finally, ClC-5 is also located in tubules positive for Tamm-
Horsfall protein, a marker of maturation of the TAL of
Henle’s loop [34]. The location of ClC-5 in maturing TAL
confirms observations in mature human and rat kidney [6,
7]. It has been speculated that ClC-5 could play a role in
the regulated Ca2+ reabsorption that occurs in TAL [35],
providing a potential explanation for the hypercalciuria
observed both in Dent’s disease [4] and ClCn5 KO mice
[10].
CONCLUSION
Our data demonstrate that the segmental distribution
of ClC-5 and H+-ATPase is essentially achieved during
early nephrogenesis in mouse and the second trimester
of gestation in humans. These data provide new insights
in the maturation of renal tubules and help to under-
stand the pathophysiology of early phenotypic variants
of Dent’s disease.
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